Episodes
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-378 Overview: Effective treatments for dementia remain elusive. In this episode, we’re discussing dementia treatment developments gathered from recent publications, covering topics of drugs, exercise, and liver disease. Stay informed and equipped to offer the latest guidance to patients with dementia and their families. Episode resource links: Ann...
Published 04/29/24
Published 04/29/24
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-377 Overview: Fluid in the middle ear, or otitis media with effusion (OME), is common in children with upper respiratory infections and typically resolves without treatment. Most guidelines do not recommend antibiotics for treatment; however, they are often prescribed, and the persistence of effusion can cause a significant impact on quality of...
Published 04/23/24
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-376 Overview: While GLP-1 agents are center stage in the medical and lay press, drugs in the class of sodium-glucose cotransporter 2 inhibitors (SGLT2is) are also quite remarkable at improving a variety of health endpoints. This episode provides an overview of studies supporting the use of SGLT2is to improve patient outcomes. Episode resource...
Published 04/15/24
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-375 Overview: Listen in as we discuss trends seen in breast cancer incidence over recent decades. Despite a notable rise in its prevalence, we’ve witnessed a decline in mortality rates. This positive shift owes itself to improvements in medication and screening efforts. Explore with us the multifaceted factors shaping this evolving landscape of...
Published 04/08/24
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-374 Overview: This episode explores the use of data from smartphone recordings as a diagnostic tool for obstructive sleep apnea (OSA), highlighting at-home testing as a more accessible, convenient, and appropriate option for some patients. Hear how the evidence can inform your practice and improve the diagnosis and treatment of patients with...
Published 04/01/24
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-373 Overview: In this episode, we review the effectiveness of intensive lifestyle intervention for type 2 diabetes mellitus (T2DM) remission. We unpack study findings on total diet replacement and consider its potential for improving weight loss and maintenance in patients. Tune in to enrich your clinical toolkit, empowering you to optimize...
Published 03/25/24
Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.56 AANP, including 0.56 AANP Pharm   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/practical-approaches-to-the-pharmacologic-treatment-of-obesity  Overview: In this podcast expert faculty will review the available options and discuss best practices for prescribing and monitoring long-term anti-obesity medications (AOM) as an important component of a chronic disease approach to obesity...
Published 03/22/24
Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.60 AANP  CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/a-comprehensive-approach-to-obesity-management  Overview: In this podcast expert faculty will discuss the Obesity Medicine Association’s 4 pillars of clinical obesity treatment as a comprehensive, evidence-based approach to management, comprised of nutrition, physical activity, behavior, and medication. The discussion will encompass...
Published 03/22/24
Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.48 AANP CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/obesity-as-a-chronic-disease-why-lifestyle-modifications-often-fails  Overview: In this 30-minute podcast, expert faculty will discuss the concept of obesity as a chronic disease. They will consider the disease burden of obesity, including adiposity-related diseases and conditions, and will examine the evidence supporting the benefits of...
Published 03/22/24
Credits: 0.75 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/cdc-preparing-for-future-hiv Overview: While the United States has made remarkable strides in HIV prevention, treatment, and care, there remains untapped potential, especially in primary care. In 2019, a staggering 1 in 8 individuals living with HIV remained unaware of their status, while countless individuals who could benefit from Pre-Exposure Prophylaxis (PrEP) have...
Published 03/21/24
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-372 Overview: Listen in as we unwrap Consumer Reports’ findings on heavy metals found in commonly consumed chocolate products. Our discussion looks into concerns about high levels of metals like lead and cadmium in these treats and offers advice on how to counsel your patients for worry-free chocolate enjoyment.  Episode resource links: A Third of...
Published 03/18/24
Credits: 0.25 AMA PRA Category 1 Credits™, 0.25 ABIM MOC or 0.35 AANP, including 0.17 AANP Pharm CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/updates-changing-landscape-covid-19  Overview: Explore the evolving landscape of COVID-19 treatment in this brief podcast. Topics reviewed include updates to payments for antivirals, areas of clinician confusion around antiviral therapy use and managing drug interactions, the status of COVID-19 rebound, and long...
Published 03/15/24
Credits: 0.75 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/hiv-101-integrating-hiv-care-and-prevention-into-primary-care  Overview: In the final episode of the three-part HIV 101 series, join our host and guest as they discuss the integration of HIV management into primary care practice.  Learn about the latest CDC guidelines for pre-exposure prophylaxis, best practices for care integration, and key considerations around...
Published 03/11/24
Credits: 0.75 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/hiv-101-connecting-lived-experiences-to-patient-centered-care  Overview: Hear honest and personal experiences from individuals living with HIV to better understand how instrumental clinician support is during diagnosis and subsequent care. You will also learn about common misconceptions held by primary care clinicians about individuals living with HIV and get caught up...
Published 03/11/24
Credits: 0.75 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/hiv-101-improving-access-to-screening-and-prevention  Overview: In the first episode of the three-part HIV 101 series, get a baseline understanding of HIV care today and learn just how simple HIV treatment is. Dr. Simmons and his guest cover topics such as syndemics, a status-neutral approach to screening, Undetectable = Untransmittable, and treatment as prevention. You...
Published 03/11/24
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-371 Overview: Beta-blockers have traditionally been used indefinitely after a myocardial infarction (MI), but this is now only recommended for a subset of patients. Listen in as faculty review new recommendations for managing patients with chronic cardiac disease, including how to determine which patients are good candidates for beta-blocker...
Published 03/11/24
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-370 Overview: Low back pain is one of the most common symptoms presenting in primary care. Listen in as we analyze the results of a recent systematic review supporting the use of a variety of effective nonnarcotic treatments for this condition. Gain evidence-based insights to help you choose the most informed option for managing low back...
Published 03/04/24
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-369 Overview: Uncover a simple, 10-second intervention—the 1-legged stance test—for predicting the risk of falling in adults. Join us as we discuss how this swift assessment can help identify patients who are prone to falls, fractures, and increased mortality. This episode brings you a practical tool to enhance patient assessments and tailor...
Published 02/26/24
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-368 Overview: In this insightful episode, we explore compelling data comparing inappropriate prescribing practices among physicians and nonphysician prescribers. This discussion covers the nuances and restrictive scope of prescribing authority and aims to take an evidence-based approach to encouraging collaboration between clinicians and expanding...
Published 02/19/24
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-367 Overview: Join us for a look at the Portfolio Diet, a plant-based approach with potential to improve cardiovascular outcomes. We’ll take you through the details of this regimen and what the evidence says about its effect on the risks of cardiovascular diseases. Stay informed on the latest research and feel prepared to answer your patients’...
Published 02/12/24
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-366 Overview: Join us as we explore the nuances of healthy eating patterns, distinguishing between time-restricted and calorie-restricted approaches. We also review a randomized controlled trial that found time-restricted eating for people with type 2 diabetes mellitus (T2DM) can benefit HbA1c levels and weight reduction. Gain insights to elevate...
Published 02/05/24
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-365 Overview: The chronic nature of irritable bowel syndrome (IBS) necessitates persistence when trialing treatment options. After reviewing key identifiers of IBS, we discuss a second-line treatment’s efficacy in reducing symptoms and improving quality of life for patients with continued IBS symptoms. Tune in for valuable insights to make...
Published 01/29/24
Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.48 AANP, including 0 AANP Pharm CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/mind-over-memory-1 Overview: In this podcast, expert faculty bring you insights from the evolving area of Alzheimer disease diagnosis, including strategies for improving identification of cognitive decline and incorporating evidence-based tools in screening. Discover the impact of advanced neuroimaging and fluid...
Published 01/24/24
Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.48 AANP, including 0.48 AANP Pharm CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/mind-over-memory-2 Overview: Embark on a captivating journey with our distinguished neurology faculty as they delve into the revolutionary world of FDA-approved monoclonal antibody therapies targeting β-amyloid in the treatment of Alzheimer disease (AD). Uncover clinical efficacy, safety nuances, and differences...
Published 01/24/24